The role and importance of endoscopic mucosal healing in ulcerative colitis

Edwards, 1963, The course and prognosis of ulcerative colitis, Gut, 4, 299, 10.1136/gut.4.4.299 Langhoz, 1994, Course of ulcerative colitis, Gastroenterology, 107, 3, 10.1016/0016-5085(94)90054-X Truelove, 1955, Cortisone in ulcerative colitis, Br Med J, 2, 1041, 10.1136/bmj.2.4947.1041 Matts, 1961, The value of rectal biopsy in the diagnosis of ulcerative colitis, Q J Med, 30, 393 Gatto, 2003, Risk of perforation after colonoscopy and sigmoidoscopy, J Natl Cancer Inst, 95, 230, 10.1093/jnci/95.3.230 Carbonnel, 1994, Colonoscopy of acute colitis, Dig Dis Sci, 39, 1550, 10.1007/BF02088063 Pera, 1987, Colonoscopy in inflammatory bowel disease, Gastroenterology, 92, 181, 10.1016/0016-5085(87)90856-0 Vega, 1999, Cytomegalovirus infection in patients with inflammatory bowel disease, Am J Gastroenterol, 94, 1053, 10.1111/j.1572-0241.1999.01013.x Cottone, 2001, Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn’s colitis, Am J Gastroenterol, 96, 773, 10.1111/j.1572-0241.2001.03620.x Pfau, 2001, Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naïve patient, Am J Gastroenterol, 96, 895, 10.1111/j.1572-0241.2001.03672.x Srinivasan, 2003, Medical therapy for ulcerative colitis, 255 Brown, 1997, Colonic spread of three rectally administered mesalazine (Pentasa) dosage forms in healthy volunteers as assessed by gamma scintigraphy, Aliment Pharmacol Ther, 11, 685, 10.1046/j.1365-2036.1997.00193.x Moum, 1999, Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time, Am J Gastroenterol, 94, 1564, 10.1111/j.1572-0241.1999.01145.x Lee, 2002, Endoscopy in inflammatory bowel disease, Gastroenterol Clin N Am, 31, 119, 10.1016/S0889-8553(01)00008-5 Truelove, 1956, Biopsy studies in ulcerative colitis, Br Med J, 1, 1315, 10.1136/bmj.1.4979.1315 Dick, 1961, Ulcerative colitis, Br Med J, 1, 160, 10.1136/bmj.1.5220.160 Dick, 1966, Persistence of mucosal abnormality in ulcerative colitis, Gut, 7, 355, 10.1136/gut.7.4.355 Powell-Tuck, 1982, Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis, Dig Dis Sci, 27, 533, 10.1007/BF01296733 Seo, 1998, Correlation between endoscopic severity and the clinical activity index in ulcerative colitis, Am J Gastroenterol, 93, 2124, 10.1111/j.1572-0241.1998.00607.x Gomes, 1986, Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease, Gut, 27, 92, 10.1136/gut.27.1.92 Floren, 1987, Histologic and colonoscopic assessment of disease extension in ulcerative colitis, Scand J Gastroenterol, 22, 459, 10.3109/00365528708991491 Buckell, 1980, Depth of ulceration in acute colitis, Gastroenterology, 79, 19, 10.1016/0016-5085(80)90069-4 Niv, 1987, Change in the extent of colonic involvement in ulcerative colitis, Am J Gastroenterol, 82, 1046 Matsumoto, 1987, Application of magnifying chromoscopy for the assessment of severity in patients with mild to moderate ulcerative colitis, Gastrointest Endosc, 46, 400, 10.1016/S0016-5107(97)70031-2 Kiesslich, 2003, Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis, Gastroenterology, 124, 880, 10.1053/gast.2003.50146 Fujiya, 2002, Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis, Gastrointest Endosc, 56, 535, 10.1016/S0016-5107(02)70439-2 Dale, 1985, Distribution of a new myelomonocytic antigen (L-1) in human peripheral blood leukocytes, Am J Clin Pathol, 84, 24, 10.1093/ajcp/84.1.24 Fagerhol, 1990, Calprotectin (the L1 leukocyte protein), 187 Roseth, 1997, Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein, Digestion, 58, 176, 10.1159/000201441 Costa, 2003, Role of faecal calprotectin as non-invasive marker of intestinal inflammation, Dig Liver Dis, 35, 642, 10.1016/S1590-8658(03)00381-5 Johansen, 1960, Isolation of an iron containing red protein from human milk, Acta Chem Scand, 14, 510, 10.3891/acta.chem.scand.14-0510 Iyer, 1993, Lactoferrin, lactoferrin receptors and iron metabolism, Eur J Clin Nutr, 47, 232 Brock, 1995, Lactoferrin, Immunol Today, 16, 417, 10.1016/0167-5699(95)80016-6 Rado, 1984, Lactoferrin biosynthesis during granulocytopoiesis, Blood, 64, 1103, 10.1182/blood.V64.5.1103.1103 Sanchez, 1992, Biological role of lactoferrin, Arch Dis Child, 67, 657, 10.1136/adc.67.5.657 Sugi, 1996, Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease, Am J Gastroenterol, 91, 927 Kayazawa, 2002, Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease, Am J Gastroenterol, 97, 360, 10.1111/j.1572-0241.2002.05470.x Kane, 2003, Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation, Am J Gastroenterol, 98, 1309, 10.1111/j.1572-0241.2003.07458.x Lennard-Jones, 1975, Assessment of severity of colitis, Gut, 16, 579, 10.1136/gut.16.8.579 Buckell, 1979, Measurement of serum proteins during attacks of ulcerative colitis as a guide to patient management, Gut, 20, 22, 10.1136/gut.20.1.22 Oshitani, 1990, Predictive factors for the response of ulcerative colitis patients during the acute-phase treatment, Digestion, 46, 107, 10.1159/000200339 Choquet, 2004, Predictors of colectomy in patients with ulcerative colitis, Rev Invest Clin, 56, 11 Chakravarty, 1993, Predictors and the rate of medical treatment failure in ulcerative colitis, Am J Gastroenterol, 88, 852 Travis, 1996, Predicting outcome in severe ulcerative colitis, Gut, 38, 905, 10.1136/gut.38.6.905 Ho, 2004, Predicting the outcome of severe ulcerative colitis, Aliment Pharmacol Ther, 19, 1079, 10.1111/j.1365-2036.2004.01945.x Seo, 2002, Evaluation of the clinical course of acute attacks in patients with ulcerative colitis through the use of an activity index, J Gastroenterol, 37, 29, 10.1007/s535-002-8129-2 Triantafillidis, 1998, Ulcerative colitis in Greece, J Clin Gastroenterol, 27, 204, 10.1097/00004836-199810000-00005 Carbonnel, 2000, Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis, Aliment Pharmacol Ther, 14, 273, 10.1046/j.1365-2036.2000.00705.x Anerson Rowe, 2000, Factors predictive of response to cyclosporine treatment for severe, steroid-resistant ulcerative colitis, Am J Gastroenterol, 95, 2000, 10.1111/j.1572-0241.2000.02186.x Farrell, 2000, High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical treatment, Gastroenterology, 118, 279, 10.1016/S0016-5085(00)70210-1 Hearing, 1999, Predictive therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating blood lymphocytes, Gut, 45, 382, 10.1136/gut.45.3.382 Tanaka, 1999, Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn’s disease from ulcerative colitis, Scand J Gastroenterol, 34, 55, 10.1080/00365529950172844 Tanaka, 2000, Simple mucosal biopsy criteria differentiating among Crohn’s disease, ulcerative colitis and other forms of colitis, Scand J Gastroenterol, 35, 281, 10.1080/003655200750024155 Wright, 1966, Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets, Am J Dig Dis, 11, 847, 10.1007/BF02233941 Sommers, 1974, Mucosal-cell counts in ulcerative and granulomatous colitis, Am J Clin Pathol, 63, 359, 10.1093/ajcp/63.3.359 Heatley, 1978, Eosinophils in the rectal mucosa, Gut, 20, 787, 10.1136/gut.20.9.787 Sarin, 1987, Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis, Dig Dis Sci, 32, 363, 10.1007/BF01296289 Oshitani, 1996, In situ comparison of phenotypical and functional activity of infiltrating cells in ulcerative colitis mucosa, J Pathol, 178, 95, 10.1002/(SICI)1096-9896(199601)178:1<95::AID-PATH402>3.0.CO;2-P Willoughby, 1979, Tissue eosinophils in ulcerative colitis, Scand J Gastroenterol, 14, 395 Choy, 1990, Activated eosinophils in chronic inflammatory bowel disease, Lancet, 336, 126, 10.1016/0140-6736(90)91651-P Bitton, 2001, Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis, Gastroenterology, 120, 13, 10.1053/gast.2001.20912 Tibble, 2000, Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease, Gastroenterology, 119, 15, 10.1053/gast.2000.8523 Kjeldsen, 1997, Serum concentrations of orosomucoid, Scand J Gastroenterol, 32, 933, 10.3109/00365529709011205 Lauritsen, 1988, Use of colonic eicosanoid concentrations as predictors of relapse in ulcerative colitis, Gut, 29, 1316, 10.1136/gut.29.10.1316 Riley, 1991, Microscopic activity in ulcerative colitis, Gut, 32, 174, 10.1136/gut.32.2.174 Jarnerot, 1985, Intensive intravenous treatment of ulcerative colitis, Gastroenterology, 89, 1005, 10.1016/0016-5085(85)90201-X Binder, 1981, Disodium cromoglycate in the treatment of ulcerative colitis and Crohn’s disease, Gut, 22, 55, 10.1136/gut.22.1.55 Saitoh, 1999, Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease, Am J Gastroenterol, 94, 3513, 10.1111/j.1572-0241.1999.01640.x Broome, 1992, Primary sclerosing cholangitis in ulcerative colitis, Gastroenterology, 102, 1877, 10.1016/0016-5085(92)90308-L D’Haens, 1993, Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis, Am J Gastroenterol, 88, 1174 Brentnall, 1996, Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis, Gastroenterology, 110, 331, 10.1053/gast.1996.v110.pm8566577 Nuako, 1998, Familial disposition for colorectal cancer in chronic ulcerative colitis, Gastroenterology, 115, 1079, 10.1016/S0016-5085(98)70077-0 Askling, 2001, Family history as a risk factor for colorectal cancer in inflammatory bowel disease, Gastroenterology, 120, 1356, 10.1053/gast.2001.24052 Devroede, 1971, Cancer risk and life expectancy of children with ulcerative colitis, N Engl J Med, 285, 17, 10.1056/NEJM197107012850103 Ekbom, 1990, Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement, Lancet, 336, 357, 10.1016/0140-6736(90)91889-I Shanahan, 2001, Relation between colitis and colon cancer, Lancet, 357, 246, 10.1016/S0140-6736(00)03630-8 Askling, 2001, Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease, Lancet, 357, 262, 10.1016/S0140-6736(00)03612-6 Greenstein, 1979, Cancer in universal and left-sided colitis, Gastroenterology, 77, 290, 10.1016/0016-5085(79)90279-8 Katzka, 1983, Assessment of colorectal cancer risk in patients with ulcerative colitis, Gastroenterology, 85, 22, 10.1016/S0016-5085(83)80224-8 Gilat, 1988, Colorectal cancer patients with ulcerative colitis, Gastroenterology, 94, 870, 10.1016/0016-5085(88)90541-0 Gyde, 1988, Colorectal cancer in ulcerative colitis, Gut, 29, 206, 10.1136/gut.29.2.206 Ekbom, 1990, Ulcerative colitis and colorectal cancer, N Engl J Med, 323, 1228, 10.1056/NEJM199011013231802 Kornbluth, 1997, Ulcerative colitis practice guidelines in adults, Am J Gastroenterol, 92, 204 Eaden, 2002, Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease, Gut, 51, v10, 10.1136/gut.51.suppl_5.v10 Rutter, 2004, Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis, Gastroenterology, 126, 451, 10.1053/j.gastro.2003.11.010 Velayos, 2004, Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk in ulcerative colitis, Gastroenterology, 126